Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Baylor1965on Jun 17, 2011 11:50am
292 Views
Post# 18729372

RE: RE: RE: RE: RE: RE: good read page 607 mention

RE: RE: RE: RE: RE: RE: good read page 607 mention

In a nutshell SCT doesn't know.

They told me that it wasn't part of the Phase II study and that they do not have access to the patients once study is completed.

The major steps in a scientific experients are:

Observation/Research
Hypothesis
Prediction
Experimentation
Conclusion

I say that they should add one:

CONTROL i.e., how is the conclusion standing up after a certain time ? e.g., 6 months, 1 year, 2 years etc...

Bullboard Posts